ProCE Banner Events

Share

Live Updates From CAPSAPP: COPD & PAH

Join us for these two independent educational sessions streaming live from the 2023 Cardiovascular and Pulmonary Summit for Advanced Practice Providers (CAPSAPP). First, expert cardiology faculty, Melisa Wilson, DNP, APRN, ACNP, BC, will review guideline-directed diagnosis and treatment of PAH including emerging therapies and personalized management plans. Next, expert pulmonary faculty Alanna Kavanaugh, EdD(c), FNP-BC, MSN, CCRN will discuss current and emerging therapies for COPD and best practices in individualizing treatment based on patient variables and the 2023 GOLD guidelines. 

Or join us in person in Orlando for the full conference – visit capsapp.com for details.

Nurse Practitioners: 2.00 Nursing contact hours, includes 2.00 hours of pharmacotherapy credit.

Physician Assistants/Physician Associates: 2.00 AAPA Category 1 CME credits

This event has expired. No longer available for credits.

Who Should Attend

Paving New Paths in Pulmonary Arterial Hypertension: Strategies for Early Diagnosis and Individualized Patient Care

This proposed educational program is intended for cardiology and pulmonary NPs and PAs who care for patients with pulmonary arterial hypertension (PAH).


Breathing New Life into COPD Care:  Leveraging the 2023 GOLD Guidelines in Optimizing Patient Outcomes

This proposed educational program is intended for pulmonary specialty and primary care NPs/PAs who care for patients with COPD.

Time and location

Friday, September 08, 2023

9:40 AM - 12:10 PM Eastern Time (ET)

In-personVirtual

Faculty
Alanna Kavanaugh, EdD(c), FNP-BC, MSN, BSN, CCRN

Director
Family Nurse Practitioner Program
College of Mount Saint Vincent
Riverdale, New York
Nurse Practitioner
Division of Pulmonary and Critical Care
Weill Cornell Medical Center
New York, New York

Melisa A. Wilson, DNP, APRN, ACNP, BC

APP Division Director- HLV
Executive Committee Chair
AdventHealth Medical Group Central Florida Division
Pulmonary Hypertension Program Coordinator
Advanced Lung Disease at Orlando
Orlando, Florida

Corinne Young, NP, FCCP

President
Association of Pulmonary Advance Practice Providers
Colorado Springs, Colorado

Agenda

9:40 AM – 10: 40 AM ET
Breathing New Life into COPD Care: Leveraging the 2023 GOLD Guidelines in Optimizing Patient Outcomes

10:40 – 11:10 AM
Break

11:10 – 12:10 PM ET
Paving New Paths in Pulmonary Arterial Hypertension: Strategies for Early Diagnosis and Individualized Patient Care (September 2023)

CME/CE Info

Paving New Paths in Pulmonary Arterial Hypertension: Strategies for Early Diagnosis and Individualized Patient Care

Goal Statement
The goal of this activity is to improve the knowledge, competence, and performance of learners in guideline-informed, evidence-based management of patients with PAH. 

Target Audience
This proposed educational program is intended for cardiology and pulmonary NPs and PAs who care for patients with pulmonary arterial hypertension (PAH). 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Determine patient need for guideline-directed diagnostic work-up for PAH based on clinical presentation
  • Construct a guideline-directed, personalized initial treatment plan for a patient with PAH
  • Outline evidence for emerging therapy approaches under investigation for management of PAH
  • Apply communication strategies that support shared decision making with patients and personalization of PAH management plans

 

Breathing New Life into COPD Care:  Leveraging the 2023 GOLD Guidelines in Optimizing Patient Outcomes

Goal Statement
The goal of this activity is to improve knowledge, competence, and performance of NPs and PAs in the pathophysiology, disease state awareness, optimal management to reduce exacerbations and hospitalizations, and emerging therapies for COPD

Target Audience
This proposed educational program is intended for pulmonary specialty and primary care NPs/PAs who care for patients with COPD.

Learning Objectives
Upon completion of this activity, learners should be better able to:  

  • Describe prevalence and pathophysiology of COPD
  • Evaluate current and emerging therapies for COPD based on their impact on disease outcomes and patient preferences
  • Develop an individualized treatment plan for COPD maintenance therapy considering patient variables, therapeutic options, and 2023 GOLD guideline recommendations, and emerging evidence 
  • Implement strategies to manage comorbidities of patients with COPD within a multidisciplinary framework

Accreditation

PER TOPIC

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE), the Academy of Physicians Associates in Cardiology (APAC) and the  Association of Pulmonary Advanced Practice Providers (APAPP). Partners for Advancing Clinical Education (PACE)  is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

ANCC Credit Designation
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

AAPA Credit Designation

Partners for Advancing Clinical Education (PACE) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.

IPCE Credit Designation

 

 

This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.

Disclosure of Conflicts of Interest 
Partners for Advancing Clinical Education (PACE) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Partners for Advancing Clinical Education (PACE), in partnership with the Academy of Physicians Associates in Cardiology (APAC) and the Association of Pulmonary Advanced Practice Providers (APAPP).

Paving New Paths in Pulmonary Arterial Hypertension: Strategies for Early Diagnosis and Individualized Patient Care 
Supported by an educational grant from Merck Sharp & Dohme, LLC.

Contact Information

For customer support please click here.

Mailing Address:

 

Practicing Clinicians Exchange
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.